Brad Pitt and Ines de Ramon shared an awkward moment on the red carpet at the world premiere of "F1" on Monday night.

Brad Pitt and Ines de Ramon were glowing on their PDA-packed date night at the “F1” premiere in New York City. Getty Images for Warner Bros. Pictures ...

Friday’s readout comes as J&J works to maintain its leadership in the CAR T space, particularly as competitor Gilead builds up to a 2026 multiple myeloma launch of anitocabtagene autoleucel (anito-cel ...

SAN FERNANDO CITY, La Union (PIA) — In celebration of Earth Day, the Provincial Government of La Union (PGLU) took a step toward environmental rehabilitation by utilizing bokashi balls—a natural water ...

DPWH Bataan 3rd District Engineer Maribel Navarro stated that the 6.7-meter wide alternate route connects Barangays Balon Anito, Ipag, and Camaya in Mariveles, along with other neighboring villages in ...

J&J and Legend are tagging on more investments to expand cell therapy production capacity despite expected upcoming competition to Carvykti.

Anito-cel has reported strong efficacy results in late-line myeloma that analysts believe are on par with market leader Carvykti but with a better side effect profile, especially on delayed ...

Physician engagement and enthusiasm for anito-cel continues to build following these data presentations and as more sites gain experience with anito-cel through iMMagine-3, our earlier-line study.

For anito-cel, better safety is in the therapy’s design. Autologous cell therapies are made by harvesting a patient’s immune cells and engineering them to go after a target.

Arcellx has shared several data cuts on anito-cel, a CAR-T being developed with Gilead Sciences' Kite Pharma to treat relapsed or refractory multiple myeloma (RRMM). | Arcellx has shared several ...

Early data from Arcellx and Gilead Sciences suggest their CAR-T therapy for multiple myeloma could offer a safety advantage over the treatment already on the market.

Anito-cel has multibillion-dollar sales potential, if it proves to be competitive on efficacy and safer from a neurotoxicity perspective than Carvykti.